The combined cGMP inspection and pre-licensing inspection (PLI), which took place between July 15 and July 26, 2024, is the ...

Biocon jumped 5.93% to Rs 340.30 after the U.S. Food and Drug Administration (FDA) has classified Biocon Biologics' facilities at Biocon Park in Bengaluru, as 'voluntary action indicated' (VAI). The ...

Bengaluru: Biocon has announced that the U.S. Food and Drug Administration (FDA) has classified Biocon Biologics' facilities ...

Biocon shares surged 5.4% after FDA classified its Bengaluru facility as Voluntary Action Indicated (VAI). The stock is up 47 ...

Texas Attorney General Ken Paxton filed a lawsuit against an El Paso doctor, claiming the doctor was illegally providing ...

Taking five or more medications daily, known as polypharmacy, is a growing issue for over 30% of older adults. This practice ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Roughly one out of every ten people in the United States are affected by rare diseases. Many of these conditions are life‑threatening, and most ...

Semaglutide has been on the FDA's shortage list since 2022, which has enabled compounding pharmacies and manufactures to make their own, unapproved versions of the drug. Novo Nordisk in October ...

Many types of medications, including over-the-counter (OTC) and prescription drugs, can help relieve joint pain due to ...

The FDA extended the Prescription Drug User Fee Act date for the biologics license application seeking approval of ...